by | Jun 29, 2026 | Uncategorized
Harvard tracked 147,000 adults 30 years and found 90–119 minutes of weekly strength training cuts death risk 13%, CVD death 19%, and neurological death 27%. Here’s the guide.
by | Jun 29, 2026 | Uncategorized
The peer-reviewed research on cartilage regeneration has evolved. Here is what the published data on Cartigenix HP® with RestorCel™ shows, and how it differs from the clinical evidence for conventional joint supplements.
by | Jun 28, 2026 | Uncategorized
June 2026 brought two FDA milestones for pediatric diabetes: an OTC kids’ CGM and teplizumab for Stage 3 Type 1 diabetes in ages 8–17. Here’s what each one does and who qualifies.
by | Jun 28, 2026 | Uncategorized
Psilocybin could receive FDA approval by late 2026 following a Trump executive order and priority review vouchers. Here’s what the evidence shows and what it means for patients.
by | Jun 28, 2026 | Uncategorized
Oklahoma expanded raw milk sales tenfold in May 2026 while active outbreaks hit Idaho, Louisiana, and California. One child developed HUS. Here’s the policy and the health data.
Recent Comments